Navigation Links
HMS Holdings Corp. Announces Q2 2009 Results and Raises 2009 Guidance
Date:7/31/2009

(in thousands) (unaudited) Six months ended June 30, ------------------- 2009 2008 ---- ---- Operating activities: Net income $12,343 $8,174 Adjustments to reconcile net income to net cash provided by operating activities: Loss on disposal of fixed assets 3 8 Depreciation and amortization 6,764 5,771 Share-based compensation expense 2,920 1,518 Decrease in deferred tax asset 391 390 Changes in assets and liabilities: Increase in accounts receivable (9,972) (5,149) Decrease in prepaid expenses and other current assets (3,414) 412 (Increase)/decrease in other assets 1 (18) Decrease in accounts payable, accrued expenses and other liabilities (3,886) (6,748) ------- ------- Net cash provided by operating activities 5,150 4,358 ----- ----- Investing activities: Purchases of property and equipment (4,290) (3,690) Investment in software (787) (477) ---- ---- Ne
'/>"/>
SOURCE HMS Holdings Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Zimmer Holdings to Present at BMO Capital Markets Ninth Annual Focus on Healthcare Conference
2. China Pharma Holdings, Inc. to Report Second Quarter 2009 Financial Results on August 12, 2009
3. American CareSource Holdings Increases ACS Networks Convenience and Quality With MinuteClinic Signing
4. Duane Reade Holdings, Inc. to Report Second Quarter 2009 Financial Results
5. SETO Holdings, Inc. Enters Into Two Additional Leases for Two New Hearing Centers in Maryland and Virginia
6. Duane Reade Holdings, Inc. Amends Terms and Extends Deadlines for Previously Announced Cash Tender Offers for Senior Secured Floating Rate Notes and Senior Subordinated Notes
7. Eastern Insurance Holdings, Inc. to Release 2nd Quarter 2009 Financial Results
8. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 Third Quarter Earnings Webcast
9. Connectyx Technologies Holdings Group, Inc. to Begin Process to Become Fully Reporting and Up List to a Higher Exchange - As Stated on Wallstreetcorner.com
10. Zimmer Holdings, Inc. Reports Second Quarter 2009 Financial Results
11. JAG Media Holdings, Inc. Announces a Further Update of the Status of Its Acquisition of CardioGenics Inc.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...cco has been the life-long focus of his research a...Lombardi Comprehensive Cancer Center at Georgetown...edit a special-edition of Cancer Epidemiology, Bi...research practices in tobacco science from researc...BP , a journal of the American Association for Can...
(Date:12/2/2009)... Reportlinker.com announces that a ...alogue: ,, Renal Disease Treatments: Products ...p0166824/Renal-Disease-Treatments-Products-and-The...n products and services, providing data for 2008 a...ket and compound annual growth rates (CAGRs) from ...
(Date:12/2/2009)... Reportlinker.com announces that a ...alogue: ,, Antibiotic Resistance and Antibioti...reportlinker.com/p0166825/Antibiotic-Resistance-an..., Provide an in-depth review of the global market...logies ,, Offer an analysis of antibiotics resi...
(Date:12/2/2009)...d cases, study finds , , WEDNESDAY, Dec....rvival rates for advanced lung cancer patients in ...udy has found. , Researchers analyzed data on m...on-small cell lung cancer (NSCLC) between 1990 and...ional Cancer Institute,s Surveillance, Epidemiolog...
(Date:12/2/2009)...etabolic syndrome, study finds , , WEDNE...n,t enough to keep overweight college football pla...tion that can lead to heart disease, a new study s...ion I colleges and found that two-thirds were obes...group of conditions that raise the risk for heart ...
Breaking Medicine News(10 mins):Health News:Lombardi's Shields leads special journal focused on tobacco research 2Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 2Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 3Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 4Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 5Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 6Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 7Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 8Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 9Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 10Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 2Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 3Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 4Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 5Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 6Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 7Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 8Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 9Health News:Gains Made in Lung Cancer Survival 2Health News:Oversized College Football Players May Face Heart Risks 2
...revent liver failure in thousands of people with H...dy published tomorrow (1 August) in the Journal o...at warfarin reduces the scarring on the liver caus...llowing the new findings in mouse models, the Impe...
... saves over $2 million in conducting the company,s...IV and safety registry - with Clinipace,s TEMPO re...h Triangle Park, NC (PRWEB) July 31, 2008 -- Clini...rect costs associated with conducing two research ...
...are Health,Systems, Inc. (Amex: ADK ), an Ohio ba...ny, today announced the refinancing of one of its ...ld, LLC, is a 50-bed single story nursing home,fac...tchen, laundry, activity and therapy rooms, a new ...
...an Association,of PPOs (AAPPO) today announced the...utives on strategies to improve the value of clini...g Value Initiative will inform AAPPO,members and p..., AAPPO President and CEO Karen Greenrose, commen...
...rtner decreases the risk of developing Alzheimer,s...study by Krister Hkansson, researcher in psycholog...den. The results were presented for the first time... in this field, and the results are astounding. Th...
...l and media,outreach efforts by The Soap and Deter...m ) on the health benefits of hand hygiene have be...a Award of Excellence., The honor is given annual... training, business and social,innovation, knowled...
Other Medicine News:Health News:Liver damage in hepatitis C patients could be treated with warfarin, says study 2Health News:Liver damage in hepatitis C patients could be treated with warfarin, says study 3Health News:On-X Life Technologies Significantly Reduces Study Management Costs with TEMPO from Clinipace 2Health News:On-X Life Technologies Significantly Reduces Study Management Costs with TEMPO from Clinipace 3Health News:On-X Life Technologies Significantly Reduces Study Management Costs with TEMPO from Clinipace 4Health News:AdCare Health Systems, Inc. Announces the Refinancing of a Nursing Home in Ohio 2Health News:AAPPO Launches Short Course Conference Call Series on Value-added Strategies for PPOs 2Health News:Living with a partner reduces risk of Alzheimer's 2Health News:SDA Hygiene Outreach Efforts Honored with Award of Excellence 2Health News:SDA Hygiene Outreach Efforts Honored with Award of Excellence 3
(Date:12/2/2009)... , PALO ALTO, Calif., Dec. 2 /PRNewswire-First...hat on November 25, 2009, Varian, Inc. filed with ...nual Report on Form 10-K for the fiscal year ended...sed through the Company,s web site at www.varianin...," and then on "10-K" in the table shown. Stockho...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Report...port is available in its catalogue: ,, Hemoglo...http://www.reportlinker.com/p0164230/Hemoglobin-A1...e seriousness of affliction and the need for effec...rgence of a significant market for monitoring the ...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Report...port is available in its catalogue: ,, Global.../www.reportlinker.com/p0166826/Global-Markets-for-...epth analysis of the global market for medications...ry disease ,, Contains global market forecasts ...
Breaking Medicine Technology:Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 2Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 3Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 4Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 5Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 6Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 7Reportlinker Adds Global Markets for Asthma and COPD Drugs 2Reportlinker Adds Global Markets for Asthma and COPD Drugs 3Reportlinker Adds Global Markets for Asthma and COPD Drugs 4Reportlinker Adds Global Markets for Asthma and COPD Drugs 5Reportlinker Adds Global Markets for Asthma and COPD Drugs 6Reportlinker Adds Global Markets for Asthma and COPD Drugs 7Reportlinker Adds Global Markets for Asthma and COPD Drugs 8Reportlinker Adds Global Markets for Asthma and COPD Drugs 9Reportlinker Adds Global Markets for Asthma and COPD Drugs 10Reportlinker Adds Global Markets for Asthma and COPD Drugs 11UC Davis researchers visualize formation of a new synapse 8885 1UC Davis researchers visualize formation of a new synapse 8885 2Group Health Cooperative Shows Investing in More Primary Care Pays for Itself 49287 1Group Health Cooperative Shows Investing in More Primary Care Pays for Itself 49287 2Group Health Cooperative Shows Investing in More Primary Care Pays for Itself 49287 3The power of prayer 3F 49285 1The power of prayer 3F 49285 2
..., Inc. today,announced that it has initiated a Pha...enance therapy in reducing the incidence of pulmon...tive pulmonary disease,(COPD). MP-376 is the compa...solution., The Phase 2, U.S. multi-center randomi...02) is expected to enroll approximately 300,COPD p...
...resented at AASLD annual meeting, Pivotal Phase I... those,who failed prior treatment, SAN FRANCISCO,... today reported that a planned interim analysis of...stigational oral hepatitis C,protease inhibitor, i...kedly increased sustained virologic response (SVR)...
Other Medicine Technology:Mpex Pharmaceuticals Announces Initiation of a Phase 2 Clinical Trial of Aerosol MP-376 in COPD 2Mpex Pharmaceuticals Announces Initiation of a Phase 2 Clinical Trial of Aerosol MP-376 in COPD 3Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 2Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 3Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 4Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 5Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 6Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 7Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 8Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 9Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 10
SmartLite Derm
Triactive
... latest evolution of Smartepil family by DEKA, a h...tion and transdermic vascular treatments. Thanks t...rtepil II Plus allows for carrying out non-invasiv...nts social life. The system is fitted with a wide ...
KOWA Automated Tonometer KT-500
Medicine Products: